Peptide-Modified Nano-Bioactive Glass for Targeted Immobilization of Native VEGF

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Tissue Engineering

Background:

• Large bone defects present challenges in regeneration due to slow vascular network formation, leading to delayed healing and implant failure.
• Effective bone regeneration requires combining potent bone graft substitutes with strategies that promote angiogenesis.

Purpose of the Study:

• To develop a novel method for immobilizing vascular endothelial growth factor (VEGF) on nanosized bioactive glass particles (nBGs) using a binding peptide.
• To ensure the immobilized VEGF retains its native state and biological activity for enhanced angiogenic processes.

Main Methods:

• Covalent coupling of a binding peptide (PR1P) to amine-functionalized nBG surfaces for VEGF immobilization.
• Controlling immobilized VEGF levels by adjusting amine density on nBG.
• In vitro assessment of endothelial cell tube formation to evaluate angiogenic activity of immobilized VEGF.

Main Results:

• High efficiency and specificity in VEGF immobilization on nBGs via the PR1P peptide.
• The biological activity of VEGF was preserved after immobilization, showing comparable angiogenic stimulation to exogenous VEGF at lower doses.
• Tailorable immobilization of VEGF within a physiologically effective range was achieved.

Conclusions:

• The developed system successfully immobilizes VEGF on nBGs using a binding peptide, a first-time application for bioactive glass nanoparticles.
• This strategy offers a promising solution to insufficient neovascularization in large bone defect regeneration.
• The controlled release and preserved activity of VEGF contribute to improved bone regeneration outcomes.